Marc Tischkowitz

Active 2000–2025

149
Papers
24,771
Citations
74
h-index
139
i10-index

Citations

Citations per year for Marc Tischkowitz1996: 1 citations1997: 1 citations1999: 1 citations2002: 4 citations2003: 11 citations2004: 28 citations2005: 25 citations2006: 26 citations2007: 49 citations2008: 84 citations2009: 76 citations2010: 87 citations2011: 70 citations2012: 88 citations2013: 117 citations2014: 172 citations2015: 206 citations2016: 212 citations2017: 229 citations2018: 226 citations2019: 834 citations2020: 972 citations2021: 974 citations2022: 876 citations2023: 644 citations2024: 1,124 citations2025: 535 citations2026: 21 citations1998: no citations, so this year is not shown2000–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,702 citing papers, 20.7% of this breakdownUnited Kingdom: 1,324 citing papers, 10.2% of this breakdownCanada: 708 citing papers, 5.4% of this breakdownGermany: 657 citing papers, 5% of this breakdownItaly: 608 citing papers, 4.7% of this breakdownChina: 571 citing papers, 4.4% of this breakdownAustralia: 550 citing papers, 4.2% of this breakdownNetherlands: 519 citing papers, 4% of this breakdownFrance: 472 citing papers, 3.6% of this breakdownSpain: 462 citing papers, 3.5% of this breakdownSweden: 241 citing papers, 1.9% of this breakdownBelgium: 230 citing papers, 1.8% of this breakdown
0%20.7%Other 30.6%

Fields

  • Biochemistry, Genetics and Molecular Biology53.8%
  • Medicine41.1%
  • Computer Science1.2%
  • Neuroscience1.1%
  • Immunology and Microbiology0.6%
  • Agricultural and Biological Sciences0.4%
  • Other1.8%

Topics

  • BRCA gene mutations in cancer10.2%
  • PARP inhibition in cancer therapy5.4%
  • DNA Repair Mechanisms5.2%
  • Cancer Genomics and Diagnostics4%
  • Genetic factors in colorectal cancer3.8%
  • Genomics and Rare Diseases3.3%
  • Other68.1%

Coauthors

All papers

Open in search
  1. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J. Hooning, Lizet E. van der Kolk, Carolien M. Kets, Muriel A. Adank, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Melissa C. Southey, Mary B. Daly, Saundra S. Buys, Ana Osório, Christoph Engel, Karin Kast, Rita K. Schmutzler, Trinidad Caldés, Anna Jakubowska, Jacques Simard, Michael Friedländer, Sue‐Anne McLachlan, Eva Macháčková, Lenka Foretová, Yen Y. Tan, Christian F. Singer, Edith Oláh, Anne‐Marie Gerdes, Brita Arver, Håkan Olsson - JAMA 2017 cited by 2,863

  2. Evidence for 28 genetic disorders discovered by combining healthcare and research data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deirdre Donnelly, Mervyn Humphreys, Alex Magee, Vivienne McConnell, Shane McKee, Susan McNerlan, Patrick J. Morrison, Gillian Rea, Fiona Stewart, Trevor Cole, Nicola Cooper, Lisa Cooper‐Charles, Helen Cox, Lily Islam, Joanna Jarvis, Rebecca Keelagher, Derek Lim, Dominic McMullan, Jenny Morton, Swati Naik, Mary O’Driscoll, Kai‐Ren Ong, Deborah Osio, Nicola Ragge, Sarah Turton, Julie Vogt, Denise Williams, Simon Bodek, Alan Donaldson, Alison Hills, Karen Low, Ruth Newbury‐Ecob, Andrew Norman, Eileen Roberts, Ingrid Scurr, Sarah Smithson, Madeleine Tooley, Steve Abbs, Ruth Armstrong, Carolyn Dunn, Simon Holden, Soo‐Mi Park, Joan Paterson, Lucy Raymond, Evan Reid, Richard Sandford, Ingrid Simonic, Marc Tischkowitz, Geoff Woods, Lisa Bradley, Joanne Comerford, Andrew Green, Sally Ann Lynch, Shirley McQuaid, Brendan Mullaney, Jonathan Berg, David Goudie, Eleni Mavrak, Joanne McLean, Catherine McWilliam, Eleanor Reavey, Tara Azam, Elaine Cleary, Andrew P. Jackson, Wayne Lam, Anne Lampe, David Moore, Mary Porteous, Emma L. Baple, Júlia Baptista and 182 more - Nature 2020 cited by 692

  3. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

    Authors: , , , , , , , , , , , , , , , , - Genetics in Medicine 2019 cited by 746

  4. Personalized early detection and prevention of breast cancer: ENVISION consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Devilee, Suzette Delaloge, Marjanka K. Schmidt, Martin Widschwendter - Nature Reviews Clinical Oncology 2020 cited by 439

  5. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lucy Side, Jacqueline Eason, Alex Murray, Antonis C. Antoniou, Douglas F. Easton, Zsofia Kote‐Jarai, Rosalind A. Eeles - Journal of Clinical Oncology 2013 cited by 824

  6. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tanja N. Fehm, Florentia Fostira, George Fountzilas, Megan Frone, Vanesa Garcia-Barberan, Pilar Garre, Marion Gauthier-Villars, Andrea Gehrig, Gord Glendon, David E. Goldgar, Lisa Golmard, Mark H. Greene, Eric Hahnen, Ute Hamann, Helen Hanson, Tiara Hassan, Julia Hentschel, Judit Horvath, Louise Izatt, Ramunas Janavicius, Yue Jiao, Esther M. John, Beth Y. Karlan, Sung-Won Kim, Irene Konstantopoulou, Ava Kwong, Anthony Laugé, Jong Won Lee, Fabienne Lesueur, Noura Mebirouk, Alfons Meindl, Emmanuelle Mouret-Fourme, Hannah Musgrave, Joanne Ngeow Yuen Yie, Dieter Niederacher, Sue K. Park, Inge Sokilde Pedersen, Juliane Ramser, Susan J. Ramus, Johanna Rantala, Muhammad U. Rashid, Florian Reichl, Julia Ritter, Andreas Rump, Marta Santamariña, Claire Saule, Gunnar Schmidt, Rita K. Schmutzler, Leigha Senter, Saba Shariff, Christian F. Singer, Melissa C. Southey, Dominique Stoppa-Lyonnet, Christian Sutter, Yen Tan, Soo Hwang Teo, Mary Beth Terry, Mads Thomassen, Marc Tischkowitz, Amanda E. Toland, Diana Torres, Ana Vega, Sebastian A. Wagner, Shan Wang-Gohrke, Barbara Wappenschmidt, Bernhard H. F. Weber, Drakoulis Yannoukakos, Amanda B. Spurdle, Douglas F. Easton, Georgia Chenevix-Trench and 2 more - Journal of Clinical Oncology 2022 cited by 275

  7. Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes

    Authors: , , , , , , , , - Nature 2022 cited by 306

  8. Hereditary diffuse gastric cancer: updated clinical practice guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Parry, Jeremy Rossaak, Haruhiko Sugimura, Magali Svrcek, Marc Tischkowitz, Toshikazu Ushijima, Hidetaka Yamada, Han‐Kwang Yang, Adrian Claydon, Joana Figueiredo, Karyn Paringatai, Raquel Seruca, Nicola Bougen‐Zhukov, Tom P. Brew, Simone Busija, Patrı́cia Carneiro, Lynn DeGregorio, Helen Fisher, Erin R. Gardner, Tanis Godwin, Katharine Nichole Holm, Bostjan Humar, C.J. Lintott, Elizabeth C. Monroe, Mark D Muller, Enrique Norero, Yasmin Nouri, Joana Paredes, João Sanches, Emily Schulpen, Ana Sofia Ribeiro, Andrew Sporle, James Whitworth, Liying Zhang, Anthony E. Reeve, Parry Guilford - The Lancet Oncology 2020 cited by 480

  9. CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants

    Authors: , , , , , , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2021 cited by 233

  10. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 cited by 179

  11. Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP

    Authors: , , , , , , , , , , , , , , - Nature Communications 2019 cited by 174

  12. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valentina Fornerone, Paola Gabaldi, Felix Haglund, Johan Hartman, Peter Horak, Tanja Jutzi, Mary Kasanicki, Simon Kreutzfeldt, Lucian Le Cornet, Rolf Lewensohn, Johan Lindberg, Carlos López, Andreas Lundqvist, Jose‐Ezequiel Martín, Gerrit A. Meijer, Susana Muñoz, Maud Ngo Camus, Claudio Nicotra, Paolo Nucíforo, Petra Oberrauch, Päivi Östling, Laura Pelz, Alejandro Piris‐Giménez, Elena Provenzano, Étienne Rouleau, John Rowell, Omar Saavedra, Giovanni Scoazec, Kenneth B. Seamon, Marc Tischkowitz, Lizet van der Kolk, Ruud van der Noll, María Vieito, Daniël J. Vis, Ana Vivancos, Christina von Gertten, Anders Wennborg, Lodewyk F.A. Wessels, Valtteri Wirta, Judith Balmañà, Giovanni Apolone, Carlos Caldas, Jonas Bergh, Ingemar Ernberg, Stefan Fröhling, Elena Garralda, Claes Karlsson, Josep Tabernero, Emile E. Voest, Jordi Rodón, Janne Lehtiö - Nature Cancer 2022 cited by 130

  13. Breast-Cancer Risk in Families with Mutations in PALB2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Poppe, Kathleen Claes, Drakoulis Yannoukakos, Patrick Concannon, Jonine L. Bernstein, Paul A. James, Douglas F. Easton, David E. Goldgar, John L. Hopper, Nazneen Rahman, Paolo Peterlongo, Heli Nevanlinna, Mary‐Claire King, Fergus J. Couch, Melissa C. Southey, Robert Winqvist, William D. Foulkes, Marc Tischkowitz - New England Journal of Medicine 2014 cited by 855

  14. Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 937

  15. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julian Barwell, Emma McCann, Alex Murray, Antonis C. Antoniou, Douglas F. Easton, on behalf of EMBRACE - JNCI Journal of the National Cancer Institute 2013 cited by 939

  16. CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.

    Authors: , , , , , , , , , , , - 2020 cited by 104

  17. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas F. Easton, Antonis C. Antoniou - European Urology 2019 cited by 246

  18. Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2014 cited by 370

  19. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kai‐Ren Ong, Camilla Huber, Jimmy Lam, Louise Taylor, Mónica Salinas, Lídia Feliubadaló, Jan C. Oosterwijk, Wendy van Zelst-Stams, Jackie Cook, Derek J. Rosario, Susan M. Domchek, Jacquelyn M. Powers, Saundra S. Buys, Karen O’Toole, Margreet G.E.M. Ausems, Rita K. Schmutzler, Kerstin Rhiem, Louise Izatt, Vishakha Tripathi, Manuel R. Teixeira, Marta Cardoso, William D. Foulkes, Armen Aprikian, Heleen van Randeraad, Rosemarie Davidson, Mark Longmuir, Mariëlle Ruijs, Apollonia T.J.M. Helderman van den Enden, Muriel A. Adank, Rachel Williams, Lesley Andrews, Declan G. Murphy, Dorothy Halliday, Lisa Walker, Annelie Liljegren, Stefan Carlsson, Ashraf Azzabi, Irene Jobson, Catherine Morton, Kylie Shackleton, Katie Snape, Helen Hanson, Marion Harris, Marc Tischkowitz, Amy Taylor, Judy Kirk, Rachel Susman, Rakefet Chen‐Shtoyerman, Allan D. Spigelman, Nicholas Pachter, Munaza Ahmed, Teresa Ramón y Cajal, Janez Žgajnar, Carole Brewer, Neus Gadea, Angela F. Brady, Theo van Os, David Gallagher, Oskar T. Johannsson, Alan Donaldson, Julian Barwell, Nicola Nicolai, Eitan Friedman, Elias Obeid, Lynn Greenhalgh, Vedang Murthy, Lucia Copáková, Sibel Saya, John McGrath, Peter Cooke and 36 more - European Urology 2019 cited by 240

  20. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 170

  21. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark J. Arends, James M. Bolton, Tjalling Bosse, John Burn, Emma J. Crosbie, Emma J. Crosbie, David N. Church, Joanna M. Cornes, Robin Crawford, K. J. Donnelly, Diana Eccles, Richard J. Edmondson, D. Gareth Evans, Ian M. Frayling, Sadaf Ghaem-Maghami, Paula Gollop, Selina Goodman, Heather Hampel, Shirley Hodgson, Noah D. Kauff, Henry C. Kitchener, Sarah J. Kitson, Fiona Lalloo, Anne Lowry, Ranjit Manchanda, Raymond F.T. McMahon, Rhona J. McVey, Usha Menon, Tracie Miles, Gabriela Möslein, Pål Møller, Kevin Monahan, Adam N. Rosenthal, Neil Ryan, Peter Sasieni, Mourad W. Seif, Pauline Skarrott, Naveena Singh, Tristan Snowsill, R. Steele, Astrid Stormoken, Helen F. Stringfellow, Marc Tischkowitz, Andrew J. Wallace, Luciya Whyte, Nafisa Wilkinson, Godfrey Wilson, Jo Wilson, Nick Wood, D. Gareth Evans - Genetics in Medicine 2019 cited by 235

  22. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C , RAD51D , BARD1 updates to tumour pathology and cancer incidence

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Medical Genetics 2022 cited by 68

  23. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Lee, Joe Dennis, David D.L. Bowtell, Nadia Traficante, Orland Dı́ez, Judith Balmañà, Stephen B. Gruber, Georgia Chenevix‐Trench, kConFab Investigators, Allan Jensen, Susanne K. Kjær, Estrid Høgdall, Laurent Castéra, Judy E. Garber, Ramūnas Janavičius, Ana Osório, Lisa Golmard, Ana Vega, Fergus J. Couch, Mark E. Robson, Jacek Gronwald, Susan M. Domchek, Julie O. Culver, Miguel de la Hoya, Douglas F. Easton, William D. Foulkes, Marc Tischkowitz, Alfons Meindl, Rita K. Schmutzler, Paul D.P. Pharoah, Antonis C. Antoniou - JNCI Journal of the National Cancer Institute 2020 cited by 165

  24. The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret Moody, Mark Churn, Jacqueline C. Newby, Mukesh B. Mukesh, Amitabha Chakrabarti, Rebecca Roylance, Philip C. Schouten, N C Levitt, Karen McAdam, Anne Armstrong, Ellen Copson, Emma McMurtry, Marc Tischkowitz, Elena Provenzano, Helena Earl - Nature 2024 cited by 47